The objective of this study was to identify maternal and infant characteristics related to alteration of amniotic fluid volume at birth.
Amniotic fluid derives from different maternal and fetal structures, including the amnion, chorion, maternal blood, fetal lungs, gastrointestinal tract, kidneys, and skin. [1] [2] [3] It is possible that alterations of one or more of the different sources will alter the amount of amniotic fluid. This is quite clear in relation to some congenital malformations, which are one of the most important causal factors in the abnormalities of amniotic fluid volume. Among these, the malformations that are most constantly associated with a markedly decreased volume of amniotic fluid are bilateral renal agenesis and obstruction of the urinary tract. Other anomalies, such as esophageal atresia, intestinal atresias, and neural tube defects (NTD), have been associated with an increased volume of amniotic fluid. However, other factors may also modify the quantity of amniotic fluid. 4 -9 Here we present the analysis of some maternal and infant characteristics, as well as perinatal outcomes, in relation to amniotic fluid volumes in a series of 27,145 consecutive malformed infants identified by the Spanish Collaborative Study of Congenital Malformations (ECEMC).
MATERIALS AND METHODS
The ECEMC is a congenital anomalies registry with a methodology based in an ongoing hospital-based, case-control study and surveillance system. Physicians examine all children born in participating hospitals across Spain during the first 3 days of life to identify major and/or minor/mild defects. For each case, the next nonmalformed infant of the same sex born in the same hospital is selected as a control subject. Once the cases and control infants have been identified (binded to any type of characteristics or prenatal exposures), the same physician interviews the mothers of the case children and control children to gather information on family history, obstetrical data, and prenatal exposures, following a unique and strict methodology. In many instances, photographs, karyotypes, imaging studies, pathology reports, and results of other studies are also available for review. 10 -12 The present study was performed using a series of 27,145 (26,614 live and 531 stillborn) consecutive malformed children identified by the ECEMC between April of 1976 and December of 1997. These infants were separated into the following three groups: 755 (3.01%) cases who had oligohydramnios, 927 (3.69%) with polyhydramnios, and 23,428 (93.30%) without any evidence of quantitative anomalies of amniotic fluid. In 2035 infants, the data on amniotic fluid were not specified.
The congenital anomalies analyzed in this study were selected either because they are known or suspected to be related to alterations of amniotic fluid volume or because of their high frequency among malformed infants (e.g., cardiovascular defects).
Comparison of the proportions of the different groups was done using a -squared analysis with K-1 or KϩC-2 degrees of freedom. For a comparison of means, we used the analysis of variance. Table 1 shows the frequency of each one of the selected defects in each of the aforementioned three study groups. Except for the frequency of colon atresia, all of the differences were statistically very significant among the groups. As one would expect, renal and urinary tract anomalies and lung defects were observed more frequently in infants with oligohydramnios, whereas intestinal and esophageal atresias were more frequent in infants with polyhydramnios. NTD also were more frequent in infants with polyhydramnios, as were central nervous system (CNS) defects other than NTD. It is interesting that cardiovascular defects were more frequent in infants with either oligo-or polyhydramnios than in children with normal amniotic fluid volume. If we look at each group, it is intriguing to see that the proportion of infants with cardiovascular defects in the group of infants with oligohydramnios is similar to the proportion of children with renal defects. Similarly, in the group with polyhydramnios, the proportion of infants with cardiovascular anomalies is higher than that of infants with esophageal atresia. These proportions could be influenced by the fact that cardiovascular defects are among the most frequent anomalies, as can be seen in the group with normal amniotic fluid volume. In fact, if we consider the total number of children with cardiovascular defects (1737), only 5.41% presented with oligohydramnios and 8.87% with polyhydramnios. In contrast to this finding, 48.62% of all cases with esophageal atresia (253) presented with polyhydramnios, and 100% of infants with bilateral renal agenesis presented with oligohydramnios.
RESULTS
It is possible that some of the studied defects are related to alter- ations of amniotic fluid volume because they are associated in the same child to anomalies that are known to produce these abnormalities of amniotic fluid. These are renal or urinary tract anomalies in infants with oligohydramnios, and NTD and esophageal and intestinal atresias in those infants with polyhydramnios. To better analyze these relationships, we excluded all infants with these defects from the respective groups of oligohydramnios and polyhydramnios. This reduced the number of infants with oligohydramnios to 472 and the number of infants with polyhydramnios to 617. Table 2 shows the comparison of the observed proportions of different congenital defects among these two groups and the total group of children with normal amniotic fluid volume. It can be observed that oligohydramnios is still related to hydrocephaly, microcephaly, other CNS defects, cardiovascular anomalies, and arthrogryposis. Conversely, polyhydramnios is related to hydrocephaly, microcephaly, cardiovascular anomalies, lung defects, unilateral renal agenesis, hydronephrosis, other renal defects, upper and lower urinary tract defects, and arthrogryposis.
To study associated variables, the same defects excluded from the two groups of infants with an abnormal volume of amniotic fluid were excluded from the group of infants with normal amniotic fluid, thus decreasing their number to 21,458. The analysis of a group of characteristics in these three study groups of malformed children appears in Tables 3 through 6 . These compare malformed children without the defects classically related to abnormal amniotic fluid and, consequently, with idiopathic oligo-and polyhydramnios and with normal volume of amniotic fluid. Table 3 shows the clinical presentation of malformed infants in each study group once we excluded those defects related to oligo-or polyhydramnios. In the groups of children with oligo-or polyhydramnios, malformed infants with only one isolated defect are less frequent than in the group of infants with normal amniotic fluid. However, the frequencies of infants with multiple congenital anomalies and children with chromosomal aberrations are higher in the group of infants with oligo-or polyhydramnios than in those with normal amniotic liquid volume. These differences were statistically very significant.
In Table 4 , it is shown that the sex ratio is similar in the three study groups, although ambiguous or absent genitalia were significantly more frequent among infants with any type of alteration of amniotic fluid volume. In addition, malformed infants with polyhydramnios had a higher frequency of twinning, and infants with oligohydramnios had a lower frequency of twinning than malformed infants with normal amniotic fluid volume. Parental consanguinity was higher in infants with polyhydramnios than in the other two groups. All of these differences were statistically significant. Table 5 analyzes the following characteristics: birth weight, gestational age, maternal and paternal ages, number of pregnancies, *Each p value corresponds to a -squared analysis comparing each defect in the three study groups of amniotic fluid.
-ϭ defects that were excluded. That is, the infants included in each group do not have these defects.
placental weight, length of the umbilical cord, and previous spontaneous abortions in each of the three study groups of malformed infants. The differences observed in all of these variables were statistically significant. Birth weight was lower in infants with any type of abnormal amniotic volume, with this reduction being more severe in those infants with oligohydramnios. However, short gestational age, although present in both groups with abnormal amniotic fluid volume, was more severe in infants with polyhydramnios. The parental ages were higher in both groups of infants with altered amniotic fluid volume, whereas the differences in the number of pregnancies appeared to be a function of a small increase in the group of infants with polyhydramnios. The same difference was seen for the mean previous spontaneous abortions. Placental weight was smaller in infants with oligohydramnios and higher in infants with polyhydramnios. Finally, the length of the umbilical cord was shorter in both groups of children with altered amniotic fluid volume compared with the group in which amniotic fluid was normal, but this reduction in length was more severe in infants with polyhydramnios. Table 6 analyzes the proportion of infants whose mothers had different diseases. Infants with oligo-or polyhydramnios had significantly higher proportions of mothers with any type of acute disease (including flu-like episodes and any other type of infections). Similarly, both groups of children with an abnormal volume of amniotic fluid had higher proportions of mothers with hypertension, diabetes mellitus, and gestational diabetes. The differences observed for maternal epilepsy, maternal cardiopathy, and maternal asthma were statistically not significant. 
DISCUSSION
The relationship between alterations of amniotic fluid volume and certain congenital defects such as bilateral renal agenesis and other renal and urinary tract defects for oligohydramnios and esophageal atresia, intestinal atresias, and NTD for polyhydramnios is well recognized. In the present analysis, we have confirmed these associations and have identified others. Cardiovascular anomalies, hydrocephaly, microcephaly, lung defects, urinary defects, and arthrogryposis were associated with polyhydramnios, whereas hydrocephaly, other CNS defects, cardiovascular anomalies, and arthrogryposis were associated with oligohydramnios. We also observed a relationship between CNS defects other than NTD and polyhydramnios, which could be explained by the fetal immobility that may result from these defects, altering fetal swallowing and consequently leading to an excessive accumulation of amniotic fluid. The shortening of the umbilical cord observed with poly-and oligohydramnios further corroborates the suggestion of fetal immobility. This shortening was more marked in infants whose mothers had polyhydramnios than in those with oligohydramnios. This could represent an earlier initiation of immobility in those cases. In children with oligohydramnios and arthrogryposis and, perhaps, lung defects, these abnormalities are the consequence of a reduced amount of amniotic fluid and subsequent fetal compression and immobility. Cardiac anomalies have been reported previ- ously in association with polyhydramnios. 3 It appears that an abnormal production of amniotic fluid is the result of associated malformations in some cases. For instance, in infants with microcephaly, 97.37% of the cases among infants with oligohydramnios and 93.88% of the cases among those with polyhydramnios have multiple congenital anomaly patterns. However, the mechanism through which these defects are related to abnormal amniotic fluid volume is unknown.
Our data confirm the observation that congenital malformations are one of the most important known causal factors in the alteration of amniotic fluid volume. 4 -9,13 However, previous studies have reported a high frequency of maternal gestational diabetes or diabetes mellitus 9, 13, 14 in infants with polyhydramnios. Our results confirm these observations, because the proportion of mothers either with gestational diabetes or diabetes mellitus is higher in infants with polyhydramnios. Nevertheless, we have also observed a higher frequency of these maternal diseases among infants with oligohydramnios, although to a lesser degree. Yaman et al. 9 observed a relationship between polyhydramnios and maternal viral infections. In our study we analyzed all acute diseases as a group, including flu-like episodes and all types of infections. These illnesses were more frequent in the mothers of infants with abnormal amniotic fluid volume than in the mothers of infants with normal volume; however, we found no difference between the group with oligohydramnios and the group with polyhydramnios. We searched the literature regarding our observation of maternal hypertension in the mothers of children with abnormal amniotic fluid volume, but found no previous report on this relationship. From our results as well as from those of the literature, it appears that some alterations of maternal health status may influence amniotic fluid volume in some situations. This may occur because of congenital defects caused by maternal disease, but in others, the mechanism is unknown. Our data also support the previous observation of an increased frequency of twinning in infants with polyhydramnios, 7, 9 but not with oligohydramnios, as reported by others. 15 The increased frequency of parental consanguinity in infants with polyhydramnios was observed previously by Stoll et al., 16 and with oligohydramnios by Alembik et al. 13 Varma et al. 14 found that infants with polyhydramnios are more frequently premature, as we also observed in the present study.
The high frequency of chromosomal aberrations in infants with polyhydramnios has also been observed by other authors, some of whom suggest that fetal chromosomal analysis should be done in every pregnancy complicated by polyhydramnios. 8, 9, 16, 17 However, we know of no such observation in infants with oligohydramnios, as we observed in our series. Our study showed that the proportions of infants with trisomy 21 and oligo-and polyhydramnios or a normal volume of amniotic fluid were not significantly different (8.08% in the oligohydramnios group, 6.04% in the polyhydramnios group, and 7.52% in the group with normal amniotic fluid). By contrast, trisomy 13, with proportions of 0.66%, 0.20%, and 4.21% in the oligohydramnios, polyhydramnios, and normal hydramnios groups, respectively, and trisomy 18, with proportions of 0.65%, 0.53%, and 0.30%, respectively, were statistically different ( p Ͻ 0.0000). Other chromosomal aberrations, including structural anomalies, were significantly more frequent among cases with oligo-or polyhydramnios (11.79% and 11.97%) than in those with normal amniotic fluid volume (3.42%) ( p Ͻ Ͻ 0.0000). These results support the recommendation that fetal chromosomal analysis should be performed in every pregnancy complicated by oligo-or polyhydramnios, especially if the fetus presents with intrauterine growth retardation or malformations detected echographically. 8, 9, 13, 16, 17 In the present analysis, we have compared the different variables in malformed infants who had decreased or increased amounts of amniotic fluid with malformed infants who apparently had normal amniotic liquid, after excluding from these groups those defects that are known to alter amniotic fluid volume. Thus, the results suggest that those variables associated with alterations of amniotic fluid could be factors that interfere with the production of the amniotic fluid by altering its sources. To test this hypothesis, we performed the same analysis in the group of 24,870 healthy control infants separated into the following three groups: 201 nonmalformed infants with oligohydramnios, 172 with polyhydramnios, and 24,497 with normal amniotic fluid volume. The results were the same as those that we obtained in malformed infants.
We would like to emphasize the fact that for some variables, we obtained results that were similar to those observed by other authors following different methodologies, further strengthening our conclusions.
